300430.SZ Stock Analysis
30
Avoid
Based on Eyestock quantitative analysis, 300430.SZ`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Beijing Chieftain Control Engineering Technology Co. Ltd. engages in the provision of pharmaceutical and biotechnology industrial automation control system. The company is headquartered in Beijing, Beijing and currently employs 1,533 full-time employees. The company went IPO on 2015-03-19. The firm focuses on automation control applications in the production process of pharmaceutical and biotechnology products, and provides automation control system products and integrated solutions to large and medium sized pharmaceutical, biotechnology companies, based on independent research and development of core technologies and independent produced key equipment and components. Its main products include four series: Fermentation and Synthesis, Purification, Product Preparation, as well as Auxiliary Process.